Abstract:We use Superlizer HA 550 to treat 70 patients suffering from herpetic neuralgia, including 52 herpes zoster (HZ) patients and 18 postherpetic neuralgia (PHN) patients. The therapy effects were evaluated by the method of visual analogic scale (VAS). The total effective rate is 88.6% and the therapeutic effects are related to the course of disease but not to the age. Superlizer treatment during the acute period of HZ not only produced a satisfactory analgesic effect but also prevented the occurrence of PHN.